Gene-expression profiling in pancreatic cancer

References

• Li C, Heidt DG, Dalerba P et al. Identification of pancreatic cancer stem cells. Cancer Res.67(3), 1030–1037 (2007).
   PubMed Web of Science ®Google Scholar
• Maitra A, Hruban RH. Pancreatic cancer. Annu. Rev. Pathol.3, 157–188 (2008).
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J. Clin.59(4), 225–249 (2009).
   PubMed Web of Science ®Google Scholar
• Lau MK, Davila JA, Shaib YH. Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States. Pancreas39(4), 458–462 (2010).
   PubMed Web of Science ®Google Scholar
• Mueller MT, Hermann PC, Heeschen C. Cancer stem cells as new therapeutic target to prevent tumour progression and metastasis. Front Biosci.2, 602–613 (2010).
   Google Scholar
• Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev.20(10), 1218–1249 (2006).
   PubMed Web of Science ®Google Scholar
• Buchholz M, Gress TM. Molecular changes in pancreatic cancer. Expert Rev. Anticancer Ther.9(10), 1487–1497 (2009).
   PubMed Web of Science ®Google Scholar
• Kern SE, Hruban RH, Hidalgo M, Yeo CJ. An introduction to pancreatic adenocarcinoma genetics, pathology and therapy. Cancer Biol. Ther.1(6), 607–613 (2002).
   PubMed Web of Science ®Google Scholar
• Hruban RH, Bishop Pitman M, Klimstra DS. Atlas of Tumor Pathology: Tumors of the Pancreas. Fourth Series Sobin LH, Albores-Saavedra J (Eds). ARP Press, Washington, DC, USA (2006).
   Google Scholar
• Kwei KA, Bashyam MD, Kao J et al. Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer. PLoS Genet.4(5), e1000081 (2008).
   PubMed Web of Science ®Google Scholar
• Kimmelman AC, Hezel AF, Aguirre AJ et al. Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc. Natl Acad. Sci. USA105(49), 19372–19377 (2008).
   PubMed Web of Science ®Google Scholar
• Jones S, Zhang X, Parsons DW et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science321(5897), 1801–1806 (2008).
   PubMed Web of Science ®Google Scholar
• Eckel F, Schneider G, Schmid RM. Pancreatic cancer: a review of recent advances. Expert Opin. Investig. Drugs15(11), 1395–1410 (2006).
   PubMed Web of Science ®Google Scholar
• Crnogorac-Jurcevic T, Efthimiou E, Capelli P et al. Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene20(50), 7437–7446 (2001).
   PubMed Web of Science ®Google Scholar
• Shi L, Reid LH, Jones WD et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol.24(9), 1151–1161 (2006).
   PubMed Web of Science ®Google Scholar
• Brazma A, Hingamp P, Quackenbush J et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet.29(4), 365–371 (2001).
   PubMed Web of Science ®Google Scholar
• Edgar R, Barrett T. NCBI GEO standards and services for microarray data. Nat. Biotechnol.24(12), 1471–1472 (2006).
   PubMed Web of Science ®Google Scholar
• Barrett T, Troup DB, Wilhite SE et al. NCBI GEO: mining tens of millions of expression profiles – database and tools update. Nucleic Acids Res.35(Database issue), D760–D765 (2007).
   PubMed Web of Science ®Google Scholar
• Parkinson H, Kapushesky M, Kolesnikov N et al. ArrayExpress update – from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res.37(Database issue), D868–D872 (2009).
   Web of Science ®Google Scholar
• Rhodes DR, Kalyana-Sundaram S, Mahavisno V et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia9(2), 166–180 (2007).
   PubMed Web of Science ®Google Scholar
• Chelala C, Hahn SA, Whiteman HJ et al. Pancreatic expression database: a generic model for the organization, integration and mining of complex cancer datasets. BMC Genomics8, 439 (2007).
   PubMed Web of Science ®Google Scholar
• Vilardell F, Iacobuzio-Donahue CA. Cancer gene profiling in pancreatic cancer. Methods Mol. Biol.576, 279–292 (2010).
   PubMedGoogle Scholar
• Argani P, Iacobuzio-Donahue C, Ryu B et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin. Cancer Res.7(12), 3862–3868 (2001).
   PubMed Web of Science ®Google Scholar
• Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, Von Hoff DD. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res.62(10), 2890–2896 (2002).
   PubMed Web of Science ®Google Scholar
• Mahadevan D, Von Hoff DD. Tumor–stroma interactions in pancreatic ductal adenocarcinoma. Mol. Cancer Ther.6(4), 1186–1197 (2007).
   PubMed Web of Science ®Google Scholar
• Crnogorac-Jurcevic T, Efthimiou E, Nielsen T et al. Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene21(29), 4587–4594 (2002).
   PubMed Web of Science ®Google Scholar
• Logsdon CD, Simeone DM, Binkley C et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res.63(10), 2649–2657 (2003).
   PubMed Web of Science ®Google Scholar
• Grutzmann R, Pilarsky C, Ammerpohl O et al. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia6(5), 611–622 (2004).
   PubMed Web of Science ®Google Scholar
• Buchholz M, Braun M, Heidenblut A et al. Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene24(44), 6626–6636 (2005).
   PubMed Web of Science ®Google Scholar
• Grutzmann R, Boriss H, Ammerpohl O et al. Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes. Oncogene24(32), 5079–5088 (2005).
   PubMed Web of Science ®Google Scholar
• Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology55(88), 2016–2027 (2008).
   PubMedGoogle Scholar
• Pilarsky C, Ammerpohl O, Sipos B et al. Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling. J. Cell. Mol. Med.12(6B), 2823–2835 (2008).
   PubMed Web of Science ®Google Scholar
• Chelala C, Lemoine NR, Hahn SA, Crnogorac-Jurcevic T. A web-based platform for mining pancreatic expression datasets. Pancreatology9(4), 340–343 (2009).
   PubMed Web of Science ®Google Scholar
• Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol.7(9), R80 (2006).
   PubMed Web of Science ®Google Scholar
• Anderson NL, Polanski M, Pieper R et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell Proteomics3(4), 311–326 (2004).
   PubMed Web of Science ®Google Scholar
• Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V et al. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology129(5), 1454–1463 (2005).
   PubMed Web of Science ®Google Scholar
• Crnogorac-Jurcevic T, Missiaglia E, Blaveri E et al. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J. Pathol.201(1), 63–74 (2003).
   PubMed Web of Science ®Google Scholar
• Friess H, Ding J, Kleeff J et al. Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell. Mol. Life Sci.60(6), 1180–1199 (2003).
   PubMed Web of Science ®Google Scholar
• Hu L, Evers S, Lu ZH, Shen Y, Chen J. Two-dimensional protein database of human pancreas. Electrophoresis25(3), 512–518 (2004).
   PubMed Web of Science ®Google Scholar
• Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL et al. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am. J. Pathol.160(4), 1239–1249 (2002).
   PubMed Web of Science ®Google Scholar
• Lu Z, Hu L, Evers S, Chen J, Shen Y. Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissue. Proteomics4(12), 3975–3988 (2004).
   PubMed Web of Science ®Google Scholar
• Maitra A, Hansel DE, Argani P et al. Global expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays. Clin. Cancer Res.9(16 Pt 1), 5988–5995 (2003).
   PubMed Web of Science ®Google Scholar
• Nakamura T, Furukawa Y, Nakagawa H et al. Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene23(13), 2385–2400 (2004).
   PubMed Web of Science ®Google Scholar
• Shen J, Person MD, Zhu J, Abbruzzese JL, Li D. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res.64(24), 9018–9026 (2004).
   PubMed Web of Science ®Google Scholar
• Tan ZJ, Hu XG, Cao GS, Tang Y. Analysis of gene expression profile of pancreatic carcinoma using cDNA microarray. World J. Gastroenterol.9(4), 818–823 (2003).
   PubMed Web of Science ®Google Scholar
• Terris B, Blaveri E, Crnogorac-Jurcevic T et al. Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am. J. Pathol.160(5), 1745–1754 (2002).
   PubMed Web of Science ®Google Scholar
• Van Heek NT, Maitra A, Koopmann J et al. Gene expression profiling identifies markers of ampullary adenocarcinoma. Cancer Biol. Ther.3(7), 651–656 (2004).
   PubMed Web of Science ®Google Scholar
• Segara D, Biankin AV, Kench JG et al. Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin. Cancer Res.11(9), 3587–3596 (2005).
   PubMed Web of Science ®Google Scholar
• Iacobuzio-Donahue CA, Maitra A, Olsen M et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol.162(4), 1151–1162 (2003).
   PubMed Web of Science ®Google Scholar
• Ishikawa M, Yoshida K, Yamashita Y et al. Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells. Cancer Sci.96(7), 387–393 (2005).
   PubMed Web of Science ®Google Scholar
• Nakata K, Nagai E, Ohuchida K et al. S100P is a novel marker to identify intraductal papillary mucinous neoplasms. Hum. Pathol.41(6), 824–831 (2010).
   PubMed Web of Science ®Google Scholar
• Harsha HC, Kandasamy K, Ranganathan P et al. A compendium of potential biomarkers of pancreatic cancer. PLoS Med.6(4), e1000046 (2009).
   PubMed Web of Science ®Google Scholar
• Yeo CJ, Cameron JL, Lillemoe KD et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann. Surg.221(6), 721–731 (1995).
   PubMed Web of Science ®Google Scholar
• Brugge WR, Lauwers GY, Sahani D, Fernandez-del Castillo C, Warshaw AL. Cystic neoplasms of the pancreas. N. Engl. J. Med.351(12), 1218–1226 (2004).
   PubMed Web of Science ®Google Scholar
• Maitra A, Fukushima N, Takaori K, Hruban RH. Precursors to invasive pancreatic cancer. Adv. Anat. Pathol.12(2), 81–91 (2005).
   PubMed Web of Science ®Google Scholar
• Deng H, Shi J, Wilkerson M, Meschter S, Dupree W, Lin F. Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens. Am. J. Clin. Pathol.129(1), 81–88 (2008).
   PubMed Web of Science ®Google Scholar
• Suomela S, Cao L, Bowcock A, Saarialho-Kere U. Interferon a-inducible protein 27 (IFI27) is upregulated in psoriatic skin and certain epithelial cancers. J. Invest. Dermatol.122(3), 717–721 (2004).
   PubMed Web of Science ®Google Scholar
• Chen R, Brentnall TA, Pan S et al. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol. Cell Proteomics6(8), 1331–1342 (2007).
   PubMed Web of Science ®Google Scholar
• Orchekowski R, Hamelinck D, Li L et al. Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. Cancer Res.65(23), 11193–11202 (2005).
   PubMed Web of Science ®Google Scholar
• Ingvarsson J, Wingren C, Carlsson A et al. Detection of pancreatic cancer using antibody microarray-based serum protein profiling. Proteomics8(11), 2211–2219 (2008).
   PubMed Web of Science ®Google Scholar
• Shi WD, Meng ZQ, Chen Z, Lin JH, Zhou ZH, Liu LM. Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysis. Cancer Lett.283(1), 84–91 (2009).
   PubMed Web of Science ®Google Scholar
• Campagna D, Cope L, Lakkur SS, Henderson C, Laheru D, Iacobuzio-Donahue CA. Gene expression profiles associated with advanced pancreatic cancer. Int. J. Clin. Exp. Pathol.1(1), 32–43 (2008).
   PubMed Web of Science ®Google Scholar
• Nakahira S, Nakamori S, Tsujie M et al. Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer. Int. J. Cancer120(6), 1355–1363 (2007).
   PubMed Web of Science ®Google Scholar
• Ina S, Hirono S, Noda T, Yamaue H. Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kd is associated with intrinsic chemoresistance. Pancreas39(4), 473–485 (2010).
   PubMed Web of Science ®Google Scholar
• Bai J, Sata N, Nagai H. Gene expression analysis for predicting gemcitabine sensitivity in pancreatic cancer patients. HPB (Oxford)9(2), 150–155 (2007).
   PubMedGoogle Scholar
• Messersmith WA, Rajeshkumar NV, Tan AC et al. Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts. Mol. Cancer Ther.8(6), 1484–1493 (2009).
   PubMed Web of Science ®Google Scholar
• Li S, Couet J, Lisanti MP. Src tyrosine kinases, Ga subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J. Biol. Chem.271(46), 29182–29190 (1996).
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell75(5), 843–854 (1993).
   PubMed Web of Science ®Google Scholar
• Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, Yakhini Z. Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS ONE4(11), e8003 (2009).
   Web of Science ®Google Scholar
• Wang L, Tang H, Thayanithy V et al. Gene networks and microRNAs implicated in aggressive prostate cancer. Cancer Res.69(24), 9490–9497 (2009).
   PubMed Web of Science ®Google Scholar
• Cheng C, Fu X, Alves P, Gerstein M. mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer. Genome Biol.10(9), R90 (2009).
   Google Scholar
• Arndt GM, Dossey L, Cullen LM et al. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer9, 374 (2009).
   PubMed Web of Science ®Google Scholar
• Bloomston M, Frankel WL, Petrocca F et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA297(17), 1901–1908 (2007).
   PubMed Web of Science ®Google Scholar
• Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J. Gastrointest. Surg.12(12), 2171–2176 (2008).
   PubMed Web of Science ®Google Scholar
• Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P, Taubert H. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int. J. Cancer126(1), 73–80 (2010).
   PubMed Web of Science ®Google Scholar
• Lee EJ, Gusev Y, Jiang J et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer120(5), 1046–1054 (2007).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li M, Wang H et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J. Surg.33(4), 698–709 (2009).
   PubMed Web of Science ®Google Scholar
• Szafranska AE, Davison TS, John J et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene26(30), 4442–4452 (2007).
   PubMed Web of Science ®Google Scholar
• Cardinali B, Castellani L, Fasanaro P et al. MicroRNA-221 and microRNA-222 modulate differentiation and maturation of skeletal muscle cells. PLoS ONE4(10), e7607 (2009).
   PubMed Web of Science ®Google Scholar
• Li Y, VandenBoom TG 2nd, Kong D et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res.69(16), 6704–6712 (2009).
   PubMed Web of Science ®Google Scholar
• Park JK, Lee EJ, Esau C, Schmittgen TD. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas38(7), e190–e199 (2009).
   PubMed Web of Science ®Google Scholar
• Wang J, Chen J, Chang P et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev. Res.2(9), 807–813 (2009).
   PubMed Web of Science ®Google Scholar
• Capurso G, Lattimore S, Crnogorac-Jurcevic T et al. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets. Endocr. Relat. Cancer13(2), 541–558 (2006).
   PubMed Web of Science ®Google Scholar
• Missiaglia E, Dalai I, Barbi S et al. Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J. Clin. Oncol.28(2), 245–255 (2010).
   PubMed Web of Science ®Google Scholar